Axial Therapeutics™ is a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological diseases. The company is the scientific leader in the biological role of the microbiome gut-brain axis and its influence on the central nervous system. Harnessing its unique expertise in the microbiome, Axial is developing small molecule drugs with defined mechanisms of action that act on new targets to mitigate the impact of metabolites and bacteria in the gut linked to neurological disease pathology, progression, and symptoms. The company is advancing a pipeline of microbiome-inspired therapeutics for diseases with significant unmet patient need, including autism and Parkinson’s disease, and is also pursuing pre-clinical discovery of gut-targeted therapies in oncology. Axial’s lead product candidate is AB-2004, a molecular therapeutic in Phase 2 clinical trials for the treatment of irritability in children with autism.

Open Positions:


In this role the Research Associate will support biology as a member of a highly matrixed drug discovery team and will be responsible for the execution and troubleshooting of various cell-based and biochemical assays and experiments.  The Research Associate will contribute to drug screening and mechanism-of-action studies for projects in immuno-oncology and neurological diseases and disorders...